Advertisement
Home Tags Opioids

Tag: Opioids

Cannabis Dispensaries Negatively Linked to Opioid-Related Death

0

Particularly strong negative association seen for dispensary count with deaths caused by synthetic opioids other than methadone

Sildenafil

McKinsey to Pay $573 Million Over Role in Opioid Crisis

0

Most of the money would be distributed to states in less than a year and be used to combat the opioid overdose epidemic

Continuing Blood Pressure Meds Safe for Those With COVID-19

Opioid-Minimizing Pain Management Feasible for Trauma Patients

0

MAST MMPR regimen includes oral acetaminophen, naproxen, gabapentin, lidocaine patches, and as-needed opioids

Okada Test Article

Opioid Use May Contribute to Risk for Pancreatic Cancer

0

At the state level, opioid death rate at four years prior predicted the initial incidence of pancreatic cancer

Neonatal Abstinence Syndrome, Maternal Opioid-Related Diagnoses Up

0

Estimated rates of NAS, maternal opioid-related diagnoses increased from 2010 to 2017 in the U.S., with variation between states

ASA: Sustained Decrease Seen in Prescription Opioid Abuse in U.S.

Gaps Found in Opioid Use Disorder Treatment During Pandemic

0

Percentage of patients receiving at least one urine test lower in March through May of 2020 versus 2019

U.S. Justice Department Sues Walmart Over Role in Opioid Crisis

0

Company violated federal law by selling prescriptions for controlled substances that its pharmacists 'knew were invalid'

ACR: Warfarin Tied to Increased Risk for Knee

Buprenorphine Rx Fills for OUD Plateau During Pandemic

0

Cash-paid prescriptions declined significantly, but no significant changes seen in those paid by public or private insurance

Outpatient Buprenorphine Dispensing Up During COVID-19

0

Findings limited to Texas, in the early days following changes in federal regulation due to the pandemic

Purdue Pharma Pleads Guilty Over Role in U.S. Opioid Epidemic

Little Change Seen in Rx of Opioids for Those at Risk for Misuse

0

After CDC guideline publication, there was a 14 percent decrease in oxycodone prescriptions, but not for other Schedule II opioids